JP2024535596A5 - - Google Patents
Info
- Publication number
- JP2024535596A5 JP2024535596A5 JP2024522260A JP2024522260A JP2024535596A5 JP 2024535596 A5 JP2024535596 A5 JP 2024535596A5 JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024535596 A5 JP2024535596 A5 JP 2024535596A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- formula
- compound
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255056P | 2021-10-13 | 2021-10-13 | |
| US63/255,056 | 2021-10-13 | ||
| US202163257212P | 2021-10-19 | 2021-10-19 | |
| US63/257,212 | 2021-10-19 | ||
| PCT/IB2022/059780 WO2023062559A1 (en) | 2021-10-13 | 2022-10-12 | Inhibitors of human immunodeficiency virus replication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535596A JP2024535596A (ja) | 2024-09-30 |
| JP2024535596A5 true JP2024535596A5 (enExample) | 2025-10-17 |
Family
ID=84044276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522260A Pending JP2024535596A (ja) | 2021-10-13 | 2022-10-12 | ヒト免疫不全ウイルス複製の阻害薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240423985A1 (enExample) |
| EP (1) | EP4415685A1 (enExample) |
| JP (1) | JP2024535596A (enExample) |
| KR (1) | KR20240074850A (enExample) |
| AU (1) | AU2022362855B2 (enExample) |
| CA (1) | CA3234219A1 (enExample) |
| CL (1) | CL2024001073A1 (enExample) |
| IL (1) | IL311982A (enExample) |
| MX (1) | MX2024004551A (enExample) |
| WO (1) | WO2023062559A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| TW202547514A (zh) | 2024-02-05 | 2025-12-16 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119462611A (zh) * | 2016-08-19 | 2025-02-18 | 吉利德科学公司 | 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物 |
| TWI687415B (zh) * | 2017-08-17 | 2020-03-11 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| KR20210033492A (ko) * | 2018-07-16 | 2021-03-26 | 길리애드 사이언시즈, 인코포레이티드 | Hiv의 치료를 위한 캡시드 억제제 |
| US11541055B2 (en) | 2018-10-24 | 2023-01-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| BR112021025655A2 (pt) * | 2019-06-19 | 2022-02-01 | Viiv Healthcare Uk No 5 Ltd | Inibidores da replicação do vírus da imunodeficiência humana |
| BR112022020933A2 (pt) * | 2020-04-15 | 2022-12-06 | Viiv Healthcare Uk No 5 Ltd | Inibidores de replicação do vírus da imunodeficiência humana |
-
2022
- 2022-10-12 MX MX2024004551A patent/MX2024004551A/es unknown
- 2022-10-12 AU AU2022362855A patent/AU2022362855B2/en active Active
- 2022-10-12 IL IL311982A patent/IL311982A/en unknown
- 2022-10-12 EP EP22797493.8A patent/EP4415685A1/en active Pending
- 2022-10-12 WO PCT/IB2022/059780 patent/WO2023062559A1/en not_active Ceased
- 2022-10-12 CA CA3234219A patent/CA3234219A1/en active Pending
- 2022-10-12 JP JP2024522260A patent/JP2024535596A/ja active Pending
- 2022-10-12 KR KR1020247014899A patent/KR20240074850A/ko active Pending
- 2022-10-12 US US18/700,402 patent/US20240423985A1/en active Pending
-
2024
- 2024-04-11 CL CL2024001073A patent/CL2024001073A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (enExample) | ||
| IL274058A (en) | Treatment of inflammatory lesions of rosacea with ivermectin | |
| JP2024535596A5 (enExample) | ||
| CN1422142A (zh) | 药用组合物 | |
| JP2022537047A5 (enExample) | ||
| JP2024170583A5 (enExample) | ||
| CN111012914A (zh) | 治疗肺部疾病的高穿透力前药组合物和医药组合物 | |
| JP2012521351A5 (enExample) | ||
| JP2022531251A5 (enExample) | ||
| CA2738070C (en) | Novel compounds for the treatment or alleviation of edema, and methods for their use | |
| JP2021534160A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| JP2024544415A5 (enExample) | ||
| KR100192745B1 (ko) | 안질환 치료용 5-메틸-이속사졸-4-카르복실산아닐리드 및 2-하이드록시에틸리덴-시아노아세트산아닐리드 | |
| JP5882296B2 (ja) | 創傷の予防及び治療のための組成物及び方法 | |
| JP2024518558A5 (enExample) | ||
| TWI510243B (zh) | 用於治療膀胱癌的組成物及方法 | |
| JP2021502337A5 (enExample) | ||
| WO2019161761A1 (zh) | 一种治疗疟疾的药物组合物 | |
| JP2016517435A5 (ja) | メロペネム誘導体及びその製造法 | |
| EP1095662B1 (fr) | Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite | |
| EP3373953A1 (fr) | Composition a action rapide d'insuline comprenant un citrate substitue | |
| RU2024112404A (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| JP2019515927A (ja) | 感染症の処置のための方法 | |
| WO2003063879A1 (en) | Remedies for glaucoma comprising bunazosin and prostaglandins |